SPARC reports net loss of Rs 41.02 crore in Q3

Sun Pharma Advanced Research Company Ltd. | Business Support | Miscellaneous | BSE: 532872 | NSE: SPARC

04 Feb 2016 Evaluate

Sun Pharma Advanced Research Company (SPARC) has reported results for third quarter ended December 31, 2015.

The company has reported a net loss of Rs 41.02 crore for the quarter ended December 31, 2015 as compared to net loss of Rs 18.91 crore for the same quarter in the previous year. However, the company’s total income has increased by 5.87% to Rs 34.10 crore for the quarter under review from Rs 32.21 crore for the corresponding quarter of the previous year.

Sun Pharma Advanced Research Company is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Peers

Company Name	CMP
Sagility	45.94
Prime Focus	352.35
Knowledge RealtyTrt.	113.71
Indegene	596.10
Syngene Internatl.	385.35
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.